Retroviruses encode a major structural protein called Gag, which is capable of selfassembling to form virus-like particles in vitro in the absence of any viral or cellular constituents (1, 2) . Assembly of HIV-1 Gag occurs predominantly on the plasma membrane (PM), a step that is indispensable for proper and efficient assembly to produce progeny virions (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) . Subsequent to virus assembly and budding, the virus undergoes a major morphological reorganization upon cleavage of the Gag polypeptides into several domains including the myristoylated matrix (myr(+)MA), capsid (CA), and nucleocapsid (NC) proteins (3, 4, (17) (18) (19) . Among the multiple functions proposed for the MA domain, its role in mediating Gagmembrane binding appears to be the most understood. Efficient binding of Gag to the PM requires a myristyl group (myr) and several basic residues localized within the N-terminal domain (3, 4, 20, 21) . The ultimate localization of HIV-1 Gag on the PM is dependent on phosphatidylinositol-(4,5)-bisphosphate (PI(4,5)P 2 ) (22-24), a prominent phospholipid localized at the inner leaflet of the PM (25) (26) (27) . Structural studies have shown that PI(4,5)P 2 binds directly to HIV-1 MA, inducing a conformational change that triggers myr exposure (28) .
Although significant progress has been made in defining the viral and cellular determinants of HIV-1 assembly and release (6) , the mechanistic pathway of Gag trafficking to the assembly sites in the infected cell and its intracellular interactions are poorly understood. Among many cellular factors proposed to interact with Gag during the virus replications cycle, (7, (29) (30) (31) (32) calmodulin (CaM) appears to be of a potential interest despite being the least understood. Subcellular distribution of CaM in HIV-infected cells was shown to be distinct from that observed in uninfected cells (33) . CaM is a highly-conserved calcium-binding protein expressed in all eukaryotic cells and is implicated in a variety of cellular functions (34) (35) (36) (37) (38) (39) . It can be localized in various subcellular locations, including the cytoplasm, within organelles, or associated with the plasma or organelle membranes (34) (35) (36) (37) (38) (39) .
Attempts to identify specific roles of CaM in virus replication and infectivity are not limited to HIV. CaM possesses a functional role in budding of Ebola virus-like particles (VLPs) by interacting with the viral matrix protein VP40 (40) . CaM also appears to play some role in the simian immunodeficiency virus (SIV) replication cycle (29, (41) (42) (43) (44) (45) . A combination of in vivo and in vitro studies revealed that CaM interacts with the HIV-1 Gag, Nef and the gp160 proteins (29, (41) (42) (43) (44) . HIV-1 Gag co-localizes with CaM in a diffuse pattern spread throughout the cytoplasm (29) . Gag binding to CaM is mediated by the MA domain and is dependent on calcium (29) . Investigation of the underlying mechanism of Gag-CaM interactions has gained some momentum recently. Our lab (46) and others (47) have shown that CaM binds directly to the MA protein in a calcium-dependent manner. Our NMR data revealed that binding of CaM to MA induces the extrusion of the myr group (46) . However, despite the evidence that the N-terminus of MA is likely to be the CaMbinding domain, severe NMR signal broadening/loss did not allow for determination of the exact MA region that interacts with CaM (46) .
In pioneering studies, Radding et al have shown that peptides from the N-terminal region of MA bind to CaM with variable affinities and in different modes (29) . These studies have prompted others to conduct SAXS experiments to elucidate the overall global features of CaM bound to short peptides derived from the MA protein (48) . Most recently, SAXS studies conducted on CaM complexed with full-length MA provided more insights on the global features of the complex (47) . However, due to the low-resolution "limitation", SAXS methods cannot provide details on the complex interface nor it can identify specific residues that are important for the formation and stabilization of the complex. To complement the SAXS studies and to elucidate the precise molecular mechanism of MA-CaM interactions, we devised multiple approaches utilizing NMR, biochemical, and biophysical methods. Short peptides derived from the MA protein have been examined. Our data revealed that a 36 amino acid peptide in the N-terminal region of MA spanning residues 8-43 (MA-8-43) constitutes the minimal CaM-binding domain. We also found that this peptide binds very tightly to CaM in a manner that is very similar to that observed for the full-length MA protein.
EXPERIMENTAL PROCEDURES
Plasmid construction: A plasmid encoding full-length (residues 1-148) Norvegicus rattus calmodulin was a kind gift from Madeline Shea (University of Iowa). The CaM sequence is identical (100% conserved) to the human CaM sequence (Swiss-port code: P62158). To construct the MA-8-43 clone, the MA-8-43 coding sequence was PCR-amplified from the pNL4-3 isolate (NCBI accession code: M15390) and ligated to the 3'-end of Small Ubiquitin-like Modifier (SUMO) gene via BamHI and XhoI sites within a pET28 vector. The resulting plasmid has a His 6 tag encoded on the Nterminus of SUMO. Both the SUMO plasmid and another encoding for His 6 -SUMO protease were kindly provided by Jin-Biao Ma (University of Alabama at Birmingham).
Protein Expression and Purification. The unmyristoylated MA (myr(-)MA) protein was expressed and purified as described (49, 50) . CaM samples have been prepared as described with minor modifications (51, 52) . CaM protein was expressed in E-coli (BL21 Codon+ RIL) cell line. To make unlabeled CaM, starter cells (20 mL) were grown overnight at 37 °C in LB media containing ampicillin (100 mg/L). Next day, cells were transferred to 2 L of LB media (100 mg/L of ampicilin) and grown until O.D. 600 reached ~0.6 -0.7, induced with 1mM isopropyl -D-thiogalactoside (IPTG) and grown for 4 hours. Cells were then harvested, spun down at 5,000 rpm and stored overnight at -80 °C. Next day, cell pellet was resuspended in 60 ml (30 ml/L of cell culture) of a buffer containing 20 mM Tris•HCl at pH 7.2 and 1 mM EDTA. Cells were then sonicated and cell lysate was spun down at 17,000 rpm for 30 min. The CaMcontaining supernatant was then purified using ion-exchange column (Q column, GE Healthcare). Fractions containing CaM protein were pooled and dialyzed overnight in a buffer containing 20 mM Tris•HCl at pH 7.4 and 10 mM CaCl 2 (wash buffer A). The dialyzed sample was loaded on phenyl sepharose column (GE Healthcare) and the CaM protein was extensively washed with wash buffer A, followed by wash buffer B (20 mM Tris•HCl at pH 7.4, 500 mM NaCl, and 10 mM CaCl 2 ) and another round with wash buffer A. CaM protein was then eluted with a buffer containing 20 mM Tris•HCl at pH 7.4 and 10 mM EDTA. CaM samples were stored at -20 °C in a buffer containing 50 mM Tris at pH 7.0 and 10 mM CaCl 2 . Protein purity was verified by SDS-page. Uniformly 15 N-and 13 C-labeled CaM samples were prepared according to a previously described protocol (53) and purified as described above for the unlabeled sample.
The His 6 -SUMO-MA-8-43 protein was expressed in E-coli (BL21 Codon+ RIL) cell line. To make the unlabeled sample of MA-8-43 peptide, the His 6 -SUMO-MA-8-43 starter cells (20 mL) were grown overnight at 37 °C in LB media containing kanamycin (50 mg/L). Next day, cells were transferred to 2 L of LB media (50 mg/L of kanamycin) and grown until O.D. 600 reached ~0.6 -0.7, induced with 1mM IPTG and grown for 4 hours. Cells were then harvested, spun down at 5,000 rpm and stored overnight at -80 °C. Next day, His 6 -SUMO-MA-8-43 cell pellet was resuspended in 40 mL of lysis buffer containing 25 mM Tris•HCl at pH 8, 500 mM NaCl, and 20 mM imidazole. Cells were sonicated and cell lysate was spun down at 17,000 rpm for 30 min. The supernatant was then loaded on nickel resin (Thermo Scientific) and protein was washed and eluted on FPLC (BioRad) using a gradient protocol (elution buffer: 25 mM Tris•HCl at pH 8, 500 mM NaCl, and 500 mM imidazole). FPLC fractions were then pooled and dialyzed overnight in a buffer containing 25 mM Tris•HCl at pH 8 and 250 mM NaCl. The MA-8-43 peptide was cleaved by SUMO protease (at 1:1000 protease:protein) and purified via nickel affinity and gel filtration chromatography methods. SUMO protease was expressed and purified as described (54) . 15 Nlabeled samples of MA-8-43 were prepared as described (53 Exothermic heats of reaction were measured at 37 °C for 19 injections. Heats of dilution were measured by titrating CaM or peptide into a buffer under identical conditions. Baseline corrections were performed by subtracting heats of dilution from the raw CaM-peptide titration data. Binding curves were analyzed and dissociation constants were determined by nonlinear least-square fitting of the baselinecorrected data using Origin 7.0 (MicroCal Corp., Northampton, MA).
Circular Dichroism (CD) Spectroscopy. CD spectra were acquired on a Jasco J815 spectropolarimeter at 25 °C from 260 to 185 nm. Scanning rate was set to 50 nm/min. Loading concentrations were 70 µM for peptides (in 20 mM sodium phosphate, pH 7) and 10 µM for CaM and the CaM•MA-8-43 complex (in 10 mM HEPES, 50 mM KCl, and 1 mM CaCl 2 ). The background signal from the buffer solution was subtracted from each spectrum.
Proteolysis Assay. Proteolytic digestion reactions were conducted on highly pure samples of myr(-)MA, CaM and myr(-)MA•CaM complex in a buffer containing 50 mM Tris-HCl (pH 7.0), 100 mM NaCl and 5mM CaCl 2 . The myr(-)MA•CaM complex was made at 1:1 stoichiometry and run on a gel filtration column (Superdex 75) to ensure sample homogeneity. Protein samples were then subjected to limited proteolysis by addition of thermolysin (from Bacillus thermoproteolyticus rokko, Sigma-Aldrich Chemicals) at 1:1000 (enzyme:complex) stoichiometry. All experiments were performed at room temperature. Digestion reactions were monitored for 24 hours via SDS-PAGE and Coomassie blue staining.
Mass spectrometry. In order to identify the peptides present in the digested samples, the CaM-MA thermolysin digests were separated on a 50 mm x 2 mm Synergi Fusion-RP column (Phenomenex, Torrance, CA) with a 30 minute ACN gradient (0-50% containing 0.1% FA) and electrosprayed into a hybrid ion trap-FT ICR mass spectrometer (LTQ-FT, Thermo Finnigan, Waltham, MA, USA). Eluting peptides were fragmented for MS/MS analysis with CID fragmentation. Fragmentation spectra were annotated by a SEAQUEST search with a custom database containing thermolysin, CaM and MA sequences. MA peptides corresponding to residues 7-43 and 7-44 were identified by MS/MS and accurate mass analyses. The intact peptides were detected as multiple charge states (4 + -10 + ) which, when deconvoluted, match the calculated mass of the peptides within 4 ppm.
RESULTS
Our recent NMR studies revealed that the majority of 1 H-15 N resonances corresponding to residues in the N-terminal region of MA (residues ~2-50) exhibit significant chemical shift changes upon binding to CaM (46) . However, extensive loss and/or broadening of the NMR signals precluded unambiguous identification of residues critical for binding. Here, we devised new approaches to further characterize CaM-MA interactions and identify the minimal binding domain of MA.
Binding of MA-11-28 peptide to CaM. In the MA protein, residues 11 to 19 form an α-helix (helix I) and residues 20-30 form a β-sheet ( Fig.  1) (28, 49, 57, 58) . Early studies suggested that a peptide made of residues 11-25 can bind to CaM with 2:1 (peptide:CaM) stoichiometry and dissociation constant of about 10 -9 M (29). Subsequent SAXS data suggested that CaM adopts a dumbbell-like structure upon binding of 2 peptide molecules (residues [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] to the Nand C-termini of CaM (48) . We chose MA-11-28 as a representative peptide to understand how it interacts with CaM. The CD spectrum obtained for MA-11-28 shows a negative band at ~200 nm, consistent with a random coil in solution ( Supplementary Fig. S1 ). Our 2D HSQC NMR data obtained for a 15 2 ). More specifically, residues F89, L105, R106, M109, T110, K115, M124, A128, F141, M144, M145, and T146 exhibited the most dramatic chemical shift changes (Δδ HN > 0.5 ppm). In comparison, only a few residues in the Nterminal domain of CaM exhibited modest chemical shift changes suggesting that MA-11-28 binds preferentially to the C-terminal domain of CaM. Our results sharply contrast previous studies, which have predicted binding of two MA-11-28 molecules to both of the N-and Ctermini of CaM (29, 48) .
Although the NMR data suggest that only one peptide is specifically bound to the Cterminal domain of CaM, we sought to determine the stoichiometry and thermodynamic parameters of interactions by isothermal titration calorimetry (ITC) methods. ITC measures heat absorbed or generated upon binding and provides values for the dissociation constant (K d ), the stoichiometry (N), and the enthalpy change (ΔH°). The K d value is then used to calculate the change in Gibbs energy (ΔG°), which together with Δ H° allows the calculation of the entropic term TΔS°. The separation of the free energy of binding into entropic and enthalpic components reveals the nature of the forces that drive the binding reaction. As shown in Figure 2 , one-site fitting of the ITC data yielded the following thermodynamic parameters: N = 1.07, K d = 4.4 ± 0.2 µM, ΔH° = -8.76 ± 0.1 kcal/mol and ΔS° = -3.96 cal/mol/deg. Again, the ITC results clearly show that only one MA-11-28 molecule is able to bind to CaM. As indicated by the sign of the heat of enthalpy, CaM binding to MA-11-28 is exothermic, suggesting that electrostatic interactions may also play a role along with the proposed hydrophobic interactions (Table 1) . Of particular note, we have previously shown that CaM interactions with the full-length MA protein are mainly hydrophobic (46) .
The presence of two hydrophobic surfaces on the N and C-terminal lobes in CaM is a prominent feature that contributes to the flexibility of the protein and allows it to bind to numerous targets. These regions are only formed upon binding of Ca 2+ (39) . A major structural consequence of helical rearrangement is the exposure of eight methionine (Met) residues that contribute ~46% to the solvent-accessible surface area of these two regions (59, 60) . Thus, Met residues become essential for the unique promiscuous binding behavior of CaM to target proteins (60 Met residues are located in the C-terminal hydrophobic lobe (Fig. 3) . Further addition of MA-11-28 led to sharpening of these signals at saturation points (4:1 peptide:CaM, Supplementary Fig. S2 ). Taken together, our NMR data demonstrate that MA-11-28 binds preferentially to the C-terminal lobe of CaM and that the Met residues are probably critical for peptide binding.
Binding of MA-31-46 peptide to CaM.
Residues 31-46 form the second α-helix (helix II) in the MA protein ( Fig. 1) (28,49,57,58) . The CD spectrum for MA-31-46 shows a negative band at ~200 nm, consistent with a random coil in solution (Supplementary Fig. S1 ). (Fig. 4) . As observed for MA-11-28, the interaction is exothermic and enthalpically driven (Table 1) . Of particular note, the N value obtained by ITC data fitting (1.46) is slightly higher than the expected 1:1 stoichiometry. This small difference is attributed to the formation of relatively viscous peptide solution at the experimental conditions (~800 µM). Taken together, our data suggest that MA-11-28 and MA-31-46 peptides bind to CaM with different affinities and interaction interface. (Table 1) . From the sign of the heat of enthalpy, CaM binding to MA-11-46 is exothermic suggesting that along with the proposed hydrophobic interactions, electrostatic interactions may also play a role.
Limited proteolysis reveals the minimal CaM-binding domain of MA.
Since various MA peptides with distinct sequence compositions and different lengths can bind to CaM with variable affinity, we sought to determine the minimal CaM-binding domain by utilizing a proteolytic digestion assay followed by analysis with mass spectrometry. Digestion reactions were conducted on the myr(-)MA•CaM complex as well as unbound myr(-)MA and CaM. The complex was subjected to limited proteolysis by addition of thermolysin (from Bacillus thermoproteolyticus rokko) at 1:1000 (enzyme:complex) molar ratio (see Experimental Procedures for more details). After 2 h, the MA protein was readily cleaved while the CaM protein was intact (Fig. 6) . Digestion of the complex has resulted in a ~5 kDa MA peptide that was resistant to proteolysis. Analysis of the digestion products by mass spectrometry revealed that the abundant MA species that was resistant to proteolysis is a peptide spanning residues 7-43 with monoisotopic mass of 4403.47 Da (Fig. 6 ) as identified by both exact mass measurements and tandem mass spectrometric sequencing. Another closely related minor species for residues 7-44 was also detected (Supplementary Fig. S3 ). On the other hand, digestion of unbound MA resulted in a cleavage of a flexible helix on the C-terminal domain leaving intact residues 1-114 (Fig. 6) (Fig. 7) . No changes in the spectrum were observed upon further additions of MA-8-43. To determine whether MA-8-43 binds to CaM in a manner similar to that observed for the full-length MA protein, we compare HSQC spectra of 15 N-labeled CaM when bound to myr(+)MA to that bound to MA-8-43 ( Supplementary Fig. S4 ). Interestingly, chemical shift changes are similar indicating that MA-8-43 binds to CaM in a manner that is very similar to that of the full-length MA protein.
ITC was used to monitor MA-8-43 binding to CaM. Thermodynamic data revealed that MA-8-43 binds to CaM with 1:1 stoichiometry (Fig.  7) . Strikingly, the binding affinity is much tighter (K d = 25 nM) than that observed for all peptides described above (Table 1) . What is even more intriguing is that the binding affinity of MA-8-43 to CaM is 32-fold tighter than that of MA-11-46, suggesting that residues Leu8, Ser9 and Gly10 of MA contribute to the stabilization of the complex. As observed for all the peptides above, MA-8-43 interaction with CaM is enthalpically driven.
As described above, although the two hydrophobic surfaces on the N-and C-terminal lobes are considered key to target protein binding, additional electrostatic interactions could also stabilize CaM-protein interactions (38, 41, 42, 63, 64) . To assess the role of electrostatic and hydrophobic factors, ITC data were obtained for MA-8-43 as titrated with CaM at high salt concentration (500 mM NaCl). Our data revealed that the binding affinity (K d = 60 nM) is only reduced by ~2-fold upon increasing the salt concentration from 50 to 500 mM (Fig.  7) , indicating that electrostatic interactions are not important in stabilizing the CaM•MA-8-43 complex. This result is also consistent with that obtained for CaM binding to the full-length MA protein, (46) indicating that interactions between CaM and MA-8-43 are mainly hydrophobic.
Far-UV CD spectra of CaM, MA-8-43, and their complex have been obtained to determine whether formation of the complex induces any major changes in the secondary structures of the peptide or CaM (Supplementary Fig. S5 ). The CD spectrum of the free peptide displays a negative band at ~200 nm consistent with a random coil, while that of the CaM protein shows two minima at 208 and 222 nm, consistent with a helical structure of the protein.
The CD spectrum of the complex is similar to that of the CaM protein with features distinctive of α -helical type (Supplementary Fig. S5 ). Binding of MA-8-43 results only in a slight increase of CD minima of CaM suggesting an increase in the α-helical character. Induction of the α-helical character of the peptide upon binding to CaM has been confirmed by NMR. The 2D HSQC data obtained for a 15 N-labeled MA-8-43 shows a narrow dispersion of the amide proton resonances, indicating a lack of ordered structure ( Supplementary Fig. S6 ). Upon binding of CaM, almost all 1 H-15 N signals of MA-8-43 exhibited substantial chemical shift changes resulting in large chemical shift dispersion, which indicates that the peptide adopts an ordered structure upon binding to CaM. Thus, it is very likely that MA-8-43 forms a helical structure upon binding to CaM.
To assess whether the hydrophobic domains of CaM are involved in MA binding, we collected 2D 1 H-13 C HMQC data on a 13 Clabeled CaM sample in the absence or presence of MA-8-43 ( Supplementary Fig. S7 ). 
DISCUSSION
CaM is a highly-conserved calcium-binding protein expressed in all eukaryotic cells and is implicated in a variety of cellular functions (34) (35) (36) (37) (38) (39) . Structural and biophysical investigation of CaM interactions with cellular proteins and peptides is central to understanding its biological function (34, (65) (66) (67) . CaM is known to interact with over 100 distinct target proteins (34, 68, 69) . We have recently shown that CaM interacts directly with the myr(+)MA protein, inducing a conformational change that triggers myr exposure (46) . In previous studies, efforts were focused on elucidating global features of CaM complexed with synthetic peptides but no attempts have been made to identify the actual binding motif of MA (29, 48) . In fact, the assumption that two MA-11-28 peptides can bind to CaM has led to conflicting conclusions about the global features of the complex (47) . In addition, although CaM interactions with peptides to mimic interactions with full-length proteins have been described in numerous reports it is still possible that non-specific contacts can occur. In this report, we have: (i) identified the interaction interface of CaM bound to short peptides derived from the MA protein, (ii) shown that MA peptides bind to CaM with variable affinities and diverse modes, (iii) identified the minimal CaM-binding domain of MA, (iv) shown that the MA-8-43 peptide interacts with CaM with a very high affinity (K d = 25 nM), and (v) provided evidence that the interactions between CaM and MA-8-43 are enthalpically driven and that hydrophobic interactions are important. Perhaps one of the most surprising results is the finding that CaM binds to the MA-8-43 peptide with a much tighter affinity (32-fold) than the MA-11-46 peptide, indicating that residues Leu8, Ser9 and Gly10 of MA are probably involved in CaM binding. In addition, compared to the full-length MA protein the higher binding affinity of MA-8-43 is probably due to a better accommodation by the CaM protein.
Previous tryptophan fluorimetry studies have shown that MA-31-46 binds to CaM with a K d of about 10 -9 M (29). However, our ITC data presented here revealed that this peptide binds CaM with a substantially weaker affinity (12 µM). Our HSQC data show that addition of MA-31-46 led to incremental chemical shift changes indicating a fast exchange between the free and bound states on the NMR scale and is consistent with µM affinity. We believe that the great discrepancy in affinity between the previously reported data and our data arises from the differences in the experimental methods and conditions. It is very unlikely that the peptide concentration used in the tryptophan fluorimetry studies (0.07 µM) can lead to accurate measurements of fluorescence signal intensity and thus determination of binding affinity. Fluorescence data reported recently for the interactions between CaM and MA have been conducted with ~5-7 µM concentrations and yielded very similar results for the binding affinity (46, 47) .
Typically, the CaM-binding domain of target proteins is a short peptide (15-30 residues long) that is hydrophobic basic and has the propensity to form an α-helix (36) . Indeed, the amphipathic character of CaM-binding peptides is a striking feature of helices I and II of MA (Fig. 8) . However, the 36-residue long MA-8-43 peptide is one of the largest CaM-binding motifs to be discovered. In addition, the ability of MA-8-43 to form two helices is another striking feature of this peptide since almost all known CaM target proteins usually possess a domain that is able to form only one α-helix. In many of the classical CaM-binding targets, hydrophobic residues usually occupy conserved positions at 1-5-10 or 1-8-14, which point to one face of the helix (36) . Although these patterns are typically found in many CaM-binding proteins, numerous unclassified examples were also identified (36) .
Analysis of MA-8-43 using a web-based tool to identify a sequence pattern with potential CaMbinding sites (68) yielded the highest score for residues Arg22-Glu40. Scores are based on several criteria including hydropathy, α-helical propensity, residue weight, residue charge, hydrophobic residue content, helical class and occurrence of particular residues. In the threedimensional structure of MA, residues Arg22-Glu40 represent the majority of helix II. However, our data show that MA-11-28 peptide binds to CaM even more tightly than MA-31-46 peptide (Table 1) . In either case, neither of these peptides contains a motif that matches any of the known patterns of CaM-binding sites. Thus, the presence of several hydrophobic residues (Leu13, Trp16, and Ile19 in helix I, and Ile34, Val35, Trp36 and Ala38 in helix II) in MA-8-43 leads us to suggest that MA may contain a novel and unclassified CaM-binding sequence. Taken together, our results combined with our recent findings (46) confirm the enormous versatility of CaM-target complex formation and suggest a novel CaM-binding mode that requires engagement of hydrophobic residues from both helices I and II of MA. In summary, the MA-8-43 peptide represents a novel target sequence that is substantially different (in length and composition) from all known CaM-binding domains.
Among the multiple functions of CaM is activation of several myristoylated proteins (e.g., MARCKS, CAP-23/NAP-22 and HIV-1 Nef) to facilitate their intracellular localization and membrane targeting (41, 42, 63, 64) . Structural studies conducted on short myristoylated peptides revealed that the myr group is involved in CaM binding, suggesting that the myr group is not only important for membrane targeting but also for mediating protein-protein interactions. However, we have recently established that although CaM acts as a trigger of myr exposure, the myr group is not involved in CaM binding (46) . As shown in Figure 1 , packing of helices I and II against the other 3 helices is a requirement for sequestration of the myr group. Thus, it is very likely that CaM binding to MA induces a conformational change that leads to partial unpacking of helices I and II and the consequent extrusion of the myr group. Partial unfolding of the MA protein upon binding to CaM has been recently suggested by Trewhella and co-workers (47) . CaM-induced unfolding of protein targets is not unusual. In some cases, this partial unfolding is considered critical for the biological function of target proteins like in enzymatically driven cleavage reactions (70) .
The N-terminal region of MA (residues 2-47) is critical for diverse Gag functions including Gag-membrane interactions, regulation of the myr switch mechanism, and binding to several cellular constituents implicated in Gag trafficking and/or gp160 incorporation (7, 17, 18, 23, 24, 28, 30, 50, 57, (71) (72) (73) . Several residues in helix I of MA (Leu8, Ser9, Leu13, Trp16, Glu17 and Lys18) are important for gp160 incorporation (74) (75) (76) , which led to the suggestion that the MA domain of Gag interacts directly with the gp160 protein via helix I (74, 77) . Furthermore, Leu8 and Ser9 have been shown to be critical for the function of the myristyl switch mechanism and membrane binding (78) (79) (80) (81) . Subsequent structural studies revealed that substitution of Leu8 and Ser9 shuts off the myristyl switch mechanism, which severely inhibit Gag targeting to the PM (50) . The finding that Leu8 and Ser9 act as stabilizing residues of the CaM-MA complex may suggest a dual role in Gag assembly.
The functional role of CaM in the HIV replication cycle could be rather more complex. Studies by Radding et al have shown that expression of the HIV-1 gp160 protein has led to a marked increase in CaM distribution (33) . The CaM-binding region was identified as a helical peptide in the gp41 protein. Deletion of this region led to diminished virus infectivity (33, 43) . Confocal microscopy data confirmed the increase in CaM distribution and showed a co-localization of CaM with the gp160 protein (33) . Thus, the interplay between gp160, CaM and Gag could be an important and underestimated event in the virus replication cycle. Although it is reasonable to hypothesize that HIV-CaM protein interactions may lead to a disruption of CaM-dependent cell-signaling pathways and contribute to immune dysfunction during HIV pathogenesis, the precise functional Fig. 1 ) are amphipathic. Hydrophobic residues are shown in red and basic residues in blue. Based on our data, hydrophobic residues are suggested to be critical for CaM binding. Figure 1 by guest on November 17, 2017
